1222. New Directions in STD Treatment and Prevention
Session: Symposium: Hot Topics in STIs
Saturday, October 5, 2013: 10:30 AM
Room: The Moscone Center: 103 (Gateway Ballroom)
Gail Bolan, MD, California Department of Public Health, Richmond, CA

Gail Bolan, M.D. Dr. Bolan is Director of the Division of STD Prevention in NCHHSTP at the Centers for Disease Control and Prevention (CDC). A graduate of Dartmouth Medical School, she completed her training in internal medicine at the University of Virginia, Charlottesville. She received subspecialty training in infectious diseases at the Tufts New England Medical Center and the Stanford Medical Center and in medical epidemiology as an Epidemic Intelligence Service (EIS) officer at CDC in the Respiratory and Special Pathogens Branch. Prior to joining CDC in February 2011, she served as the Chief of the STD Control Branch at the California Department of Public Health from 1997 to 2011, and as the Director of the San Francisco City and County STD Prevention and Control Program and as Medical Director of San Francisco City Clinic from 1987 to 1997. She directed the California STD/HIV Prevention Training Center for over 20 years. Bolan is a leader in the field of STD Prevention and is nationally recognized for her contributions in applied research on the epidemiology and prevention of STDs, for implementation of science-based programs and for effective STD program policy development. Dr. Bolan has authored or co-authored over 125 scientific publications. She has served on the CDC HIV/STD Prevention Advisory Committee, CDC Office of Infectious Diseases Board of Scientific Counselors, and the American STD Association (ASTDA) Executive Committee. She is past chair of the National Coalition of STD Directors (NCSD) and past vice chair of the American Social Health Association (ASHA) Board of Directors.



See more of: Hot Topics in STIs
See more of: Symposium
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.